Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Apple
AAPL
|
+$1.17B |
| 2 |
Valero Energy
VLO
|
+$265M |
| 3 |
Advanced Micro Devices
AMD
|
+$258M |
| 4 |
Progressive
PGR
|
+$257M |
| 5 |
O'Reilly Automotive
ORLY
|
+$236M |
Top Sells
| 1 |
NVIDIA
NVDA
|
+$531M |
| 2 |
Meta Platforms (Facebook)
META
|
+$483M |
| 3 |
Intel
INTC
|
+$403M |
| 4 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$389M |
| 5 |
Merck
MRK
|
+$341M |
Sector Composition
| 1 | Technology | 31.79% |
| 2 | Financials | 11.71% |
| 3 | Healthcare | 11.07% |
| 4 | Consumer Discretionary | 10.64% |
| 5 | Communication Services | 8.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
4D Molecular Therapeutics
FDMT
$330M
| $2.59M | ﹤0.01% |
123,468
+14,718
| +14% | +$309K |
|
|
UNIT
2227
Uniti Group
UNIT
$1.75B
| $2.59M | ﹤0.01% |
885,504
-242
| -0% | -$707 |
|
|
PSTL
2228
Postal Realty Trust
PSTL
$394M
| $2.57M | ﹤0.01% |
193,060
-4,666
| -2% | -$62.2K |
|
2229
QuantumScape
QS
$5.01B
| $2.57M | ﹤0.01% |
521,880
-111,305
| -18% | -$548K |
|
2230
Avanos Medical
AVNS
$576M
| $2.56M | ﹤0.01% |
128,365
| – | – |
|
2231
Axogen
AXGN
$773M
| $2.56M | ﹤0.01% |
353,136
| – | – |
|
2232
ImmunityBio
IBRX
$2.45B
| $2.55M | ﹤0.01% |
403,528
-102,897
| -20% | -$650K |
|
2233
Gorman-Rupp
GRC
$1.15B
| $2.55M | ﹤0.01% |
69,428
| – | – |
|
2234
Arcus Biosciences
RCUS
$1.22B
| $2.55M | ﹤0.01% |
167,301
+40,082
| +32% | +$610K |
|
|
NWLI
2235
DELISTED
National Western Life Group, Inc. Class A
NWLI
| $2.54M | ﹤0.01% |
5,121
+287
| +6% | +$143K |
|
2236
iQIYI
IQ
$2.52B
| $2.54M | ﹤0.01% |
692,486
+52,900
| +8% | +$194K |
|
2237
Anika Therapeutics
ANIK
$124M
| $2.53M | ﹤0.01% |
100,076
-96,100
| -49% | -$2.43M |
|
2238
Stoke Therapeutics
STOK
$1.31B
| $2.53M | ﹤0.01% |
187,351
+67,540
| +56% | +$912K |
|
2239
Transcat
TRNS
$712M
| $2.53M | ﹤0.01% |
21,103
+567
| +3% | +$67.9K |
|
2240
Disc Medicine
IRON
$2.1B
| $2.52M | ﹤0.01% |
55,921
+16,316
| +41% | +$735K |
|
2241
Metallus
MTUS
$710M
| $2.51M | ﹤0.01% |
124,022
-31,345
| -20% | -$635K |
|
|
DHC
2242
Diversified Healthcare Trust
DHC
$1.09B
| $2.5M | ﹤0.01% |
820,378
+91,451
| +13% | +$279K |
|
2243
Sprinklr
CXM
$1.93B
| $2.49M | ﹤0.01% |
259,167
-614,754
| -70% | -$5.91M |
|
2244
Methanex
MEOH
$3.08B
| $2.49M | ﹤0.01% |
51,550
| – | – |
|
2245
Quanex
NX
$697M
| $2.49M | ﹤0.01% |
89,972
+2,944
| +3% | +$81.4K |
|
|
INST
2246
DELISTED
Instructure Holdings, Inc.
INST
| $2.49M | ﹤0.01% |
106,229
+47,308
| +80% | +$1.11M |
|
2247
indie Semiconductor
INDI
$774M
| $2.48M | ﹤0.01% |
401,947
+18,187
| +5% | +$112K |
|
2248
Jack in the Box
JACK
$342M
| $2.48M | ﹤0.01% |
48,648
+462
| +1% | +$23.5K |
|
2249
ARKO Corp
ARKO
$585M
| $2.48M | ﹤0.01% |
394,873
+121,709
| +45% | +$763K |
|
2250
LegalZoom.com
LZ
$1.9B
| $2.47M | ﹤0.01% |
294,459
-422,623
| -59% | -$3.55M |
|